Electroencephalographic abnormalities in clozapine-treated patients: a cross-sectional study

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Electrophysiology

Background:

• Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
• Electroencephalogram (EEG) monitoring is sometimes employed during psychiatric treatment.
• Understanding potential neurological effects of clozapine is crucial for patient management.

Purpose of the Study:

• To investigate the prevalence and nature of electroencephalogram (EEG) abnormalities in patients undergoing clozapine treatment.
• To determine if EEG findings correlate with the dosage or duration of clozapine therapy.

Main Methods:

• A cross-sectional study involving 87 psychiatric patients receiving clozapine.
• Digital 32-channel electroencephalogram (EEG) recordings were obtained.
• Visual analysis of EEG data was performed to identify abnormalities.

Main Results:

• EEG abnormalities were detected in 63.2% of the patients studied.
• Slowing and epileptiform activities were observed in 41.4% of patients.
• No significant association was found between EEG abnormalities and clozapine dose or duration of treatment.

Conclusions:

• A high proportion of patients on clozapine exhibit EEG abnormalities.
• The observed EEG changes, such as slowing and epileptiform activity, appear independent of clozapine dosage and treatment length.
• Further research may be warranted to explore the clinical significance and underlying mechanisms of these EEG findings.